Next, since oxidative damage leads to GRP78 dysfunction and consequent aberrant activation of UPR, as previously observed in down syndrome (DS) [40,41], we investigated the activation of the three major arms of UPR pathways mediated by PERK, IRE, and ATF6. The gene discussed is ATF6; the disease is Dravet syndrome.